Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical pathways for managing patients receiving interleukin 2.

S A Mavroukakis1, P M Muehlbauer, R L White

  • 1Sharon_Mavroukakis@nih.gov

Clinical Journal of Oncology Nursing
|March 22, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Redshift Evolution of Damped Lyman Alpha Absorbers and the Epoch of Galaxy Formation.

Annals of the New York Academy of Sciences·2015
Same author

Lysine cataboism and α-aminoadipate synthesis in Streptomyces clavuligerus.

Applied microbiology and biotechnology·2012
Same author

A thermogravimetry-capillary gas chromatography/mass spectrometry interface.

Analytical chemistry·2011
Same author

The detection of tubercle bacilli by fluorescence microscopy.

The New England journal of medicine·2010
Same author

Surgical management of solitary metastatic melanoma.

Acta chirurgica Belgica·2009
Same author

System design of a cochlear implant.

IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society·2009
Same journal

How Can Oncology Nurses Learn to See Beyond the Numbers?

Clinical journal of oncology nursing·2026
Same journal

Care of Patients Receiving Abemaciclib: Results From Clinical Trials and a Healthcare Provider Survey.

Clinical journal of oncology nursing·2026
Same journal

The Role of Oncology Nurses in National Breast and Cervical Cancer Screening Programs.

Clinical journal of oncology nursing·2026
Same journal

Technology-Assisted Nutrition Education Program for Patients With Cancer Undergoing Gastrectomy: A Quasi-Experimental Study.

Clinical journal of oncology nursing·2026
Same journal

The Hidden Biology of Life Experience: Using SEMOARS + GEM and Precision Health for Psychoneurologic Symptoms in Hematologic Malignancies.

Clinical journal of oncology nursing·2026
Same journal

GLP-1 Medications in Oncology Nursing Practice.

Clinical journal of oncology nursing·2026
See all related articles

Interleukin 2 (IL-2) is a biologic therapy used for metastatic cancers. Understanding its effects on the immune system and predictable side effects like flu-like symptoms is crucial for patient care.

Area of Science:

  • Immunology
  • Oncology
  • Pharmacology

Background:

  • Biologic therapies, including interleukin 2 (IL-2), are increasingly used in cancer and HIV treatment.
  • Clinicians require specialized knowledge to manage patients receiving these advanced treatments.
  • IL-2 is approved for metastatic renal cell carcinoma and melanoma, with ongoing trials for other cancers.

Purpose of the Study:

  • To provide an overview of the immune system's components affected by IL-2.
  • To discuss the approved uses and ongoing research for IL-2 in oncology.
  • To outline the predictable side effects of IL-2 and strategies for management.

Main Methods:

  • Review of the immune system's interaction with IL-2.
  • Analysis of IL-2's approved indications and clinical trial status.

Related Experiment Videos

  • Discussion of IL-2 administration variables influencing side effect severity.

    • Main Results:

    • IL-2 impacts specific elements of the immune system.
    • Flu-like symptoms are the most common side effect across administration methods.
    • Side effect severity is dose, route, and schedule dependent.

    Conclusions:

    • Clinical pathways are effective tools for managing IL-2 toxicities.
    • Anticipating and managing IL-2 side effects ensures patient safety and treatment efficacy.
    • Enhanced understanding of IL-2's immunologic effects supports its clinical application.